These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11364170)

  • 1. Study confirms that protease inhibitor cocktail can delay HIV disease progression and death.
    Randall P
    NIAID AIDS Agenda; 1997 Mar; ():1-2. PubMed ID: 11364170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study shows three drugs better than two.
    AIDS Alert; 1997 Apr; 12(4):39. PubMed ID: 11364145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
    Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM
    N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus.
    Wintergerst U; Hoffmann F; Sölder B; Notheis G; Petropoulou T; Eberle J; Gürtler L; Belohradsky BH
    Pediatr Infect Dis J; 1998 Jun; 17(6):495-9. PubMed ID: 9655541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV-therapy: as early and as intensive as possible].
    Dtsch Med Wochenschr; 1997 Oct; 122(41):A27. PubMed ID: 9378051
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.
    Clark NM; Dieng Sarr A; Sankalé JL; Kanki PJ; Kazanjian P; Winfield R; Markovitz DM
    AIDS; 1998 Dec; 12(18):2506-7. PubMed ID: 9875594
    [No Abstract]   [Full Text] [Related]  

  • 8. ACTG 320: last of the body count trials?
    PI Perspect; 1997 Mar; (No 21):7. PubMed ID: 11364215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data in from first head-to-head protease inhibitor.
    AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961
    [No Abstract]   [Full Text] [Related]  

  • 10. 3-drug therapy reduces deaths and new AIDS-related illnesses by 50%.
    Baker R
    BETA; 1997 Mar; ():3-4. PubMed ID: 11364527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV trial stopped early after good results.
    Boulton A
    BMJ; 1997 Mar; 314(7082):699. PubMed ID: 9116542
    [No Abstract]   [Full Text] [Related]  

  • 13. New study shows efavirenz effective with d4T and 3TC.
    AIDS Alert; 1999 May; 14(5):60. PubMed ID: 11366404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The art of 'HAART': researchers probe the potential and limits of aggressive HIV treatments.
    Stephenson J
    JAMA; 1997 Feb; 277(8):614-6. PubMed ID: 9039864
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug shows potency against HIV.
    Dent Today; 1996 May; 15(5):22, 26. PubMed ID: 9567867
    [No Abstract]   [Full Text] [Related]  

  • 16. ACTG 343: three drugs better than two for maintaining HIV suppression.
    Bowersox J
    NIAID AIDS Agenda; 1998 Mar; ():1-2, 10-1. PubMed ID: 11365088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double protease inhibitor regimens with amprenavir show promise.
    AIDS Patient Care STDS; 1998 Apr; 12(4):317-8. PubMed ID: 11361962
    [No Abstract]   [Full Text] [Related]  

  • 18. Protease inhibitors: major study stopped when 3-drug arm proves superior.
    AIDS Treat News; 1997 Mar; (No 266):7-8. PubMed ID: 11364247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: application to a clinical trial.
    Cook J; Dasbach E; Coplan P; Markson L; Yin D; Meibohm A; Nguyen BY; Chodakewitz J; Mellors J
    AIDS Res Hum Retroviruses; 1999 Apr; 15(6):499-508. PubMed ID: 10221527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
    Allerg Immunol (Paris); 1998 Apr; 30(4):123-4. PubMed ID: 9631694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.